Key result
Cardiac magnetic resonance imaging provides valuable prognostic information for ventricular arrhythmia risk and serves as a useful tool for guiding ventricular tachycardia ablation in patients with coronary artery disease.
Why the study?
Does cardiac magnetic resonance (CMR) imaging provide useful prognostic information and guidance for ventricular arrhythmia therapies in patients with coronary artery disease?
Does cardiac magnetic resonance (CMR) imaging provide useful prognostic information and guidance for ventricular arrhythmia therapies in patients with coronary artery disease?
This review highlights the utility of CMR for myocardial tissue characterization, scar assessment, and guiding ventricular arrhythmia therapies in patients with CAD.
CMR supports refined ventricular arrhythmia risk stratification and ablation planning in CAD; leaves open prospective outcome trials before routine adoption.
Cardiac magnetic resonance (CMR) imaging is currently gold standard for myocardial tissue characterization and scar assessment. CMR serves potential prognostic information in patients with coronary artery disease (CAD) for both ventricular arrhythmia risk, as well as it may also be used for guiding VT ablation procedures. This review is focused on the usefulness of CMR for ventricular arrhythmia therapies in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Yalın et al. (2015) conducted a review in Coronary Artery Disease. Cardiac Magnetic Resonance (CMR) was evaluated. Cardiac magnetic resonance imaging provides valuable prognostic information for ventricular arrhythmia risk and serves as a useful tool for guiding ventricular tachycardia ablation in patients with coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: